Binding of daptomycin to anionic lipid vesicles is reduced in the presence of lysyl-phosphatidylglycerol

Antimicrobial Agents and Chemotherapy

Volumn 60, Issue 8, 2016, Pages 5051-5053

  Khatib, Tala O ^a   Stevenson, Heather ^a   Yeaman, Michael R ^b   Bayer, Arnold S ^b   Pokorny, Antje ^a  

^a UNIVERSITY OF NORTH CAROLINA WILMINGTON   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; DAPTOMYCIN; PHOSPHATIDYLGLYCEROL; ANTIINFECTIVE AGENT; LIPID; LYSINE; LYSYLPHOSPHATIDYLGLYCEROL;

ANTIBIOTIC RESISTANCE; ARTICLE; BINDING AFFINITY; CELL MEMBRANE; DESORPTION; DISSOCIATION CONSTANT; LIPID COMPOSITION; LIPID VESICLE; NONHUMAN; PRIORITY JOURNAL; STAPHYLOCOCCUS AUREUS; SURFACE CHARGE; TEMPERATURE; CHEMISTRY; DRUG EFFECTS; METABOLISM; MICROBIAL SENSITIVITY TEST;

ANTI-BACTERIAL AGENTS; CELL MEMBRANE; DAPTOMYCIN; LIPIDS; LYSINE; MICROBIAL SENSITIVITY TESTS; PHOSPHATIDYLGLYCEROLS;

EID: 84979273005     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00744-16     Document Type: Article

References (21)

1. Houtsmuller UM, van Deenen L. 1963. Identification of a bacterial phospholipid as an O-ornithine ester of phosphatidylglycerol. Biochim Biophys Acta 70:211-213. http://dx.doi.org/10.1016/0006-3002(63)90743-1.
2. Kuhn S, Slavetinsky CJ, Peschel A. 2015. Synthesis and function of phospholipids in Staphylococcus aureus. Int J Med Microbiol 305:196-202. http://dx.doi.org/10.1016/j.ijmm.2014.12.016.
3. O'Leary WM, Wilkinson SG. 1988. Gram-positive bacteria, p 117-201. In Ratledge C, Wilkinson SG (ed), Microbial lipids, vol.1. Academic Press, San Diego, CA.
4. Short SA, White DC. 1971. Metabolism of phosphatidylglycerol, lysyl-phosphatidylglycerol, and cardiolipin of Staphylococcus aureus. J Bacteriol 108:219-226.
5. Jones T, Yeaman MR, Sakoulas G, Yang S-J, Proctor RA, Sahl H-G, Schrenzel J, Xiong YQ, Bayer AS. 2008. Failures in clinical treatment of Staphylococcus aureus infection with daptomycin are associated with alterations in surface charge, membrane phospholipid asymmetry, and drug binding. Antimicrob Agents Chemother 52:269-278. http://dx.doi.org/10.1128/AAC.00719-07.
6. Mishra NN, Bayer AS. 2013. Correlation of cell membrane lipid profiles with daptomycin resistance in methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 57:1082-1085. http://dx.doi.org/10.1128/AAC.02182-12.
7. Mishra NN, Bayer AS, Weidenmaier C, Grau T, Wanner S, Stefani S, Cafiso V, Bertuccio T, Yeaman MR, Nast CC, Yang SJ. 2014. Phenotypic and genotypic characterization of daptomycin-resistant methicillin-resistant Staphylococcus aureus strains: relative roles of mprF and dlt operons. PLoS One 9:e107426. http://dx.doi.org/10.1371/journal.pone.0107426.
8. Mishra NN, Yang SJ, Sawa A, Rubio A, Nast CC, Yeaman MR, Bayer AS. 2009. Analysis of cell membrane characteristics of in vitro-selected daptomycin-resistant strains of methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 53:2312-2318. http://dx.doi.org/10.1128/AAC.01682-08.
9. Nishi H, Komatsuzawa H, Fujiwara T, McCallum N, Sugai M. 2004. Reduced content of lysyl-phosphatidylglycerol in the cytoplasmic membrane affects susceptibility to moenomycin, as well as vancomycin, gentamicin, and antimicrobial peptides, in Staphylococcus aureus. Antimicrob Agents Chemother 48:4800-4807. http://dx.doi.org/10.1128/AAC.48.12.4800-4807.2004.
10. Staubitz P, Neumann H, Schneider T, Wiedemann I, Peschel A. 2004. MprF-mediated biosynthesis of lysylphosphatidylglycerol, an important determinant in staphylococcal defensin resistance. FEMS Microbiol Lett 231:67-71. http://dx.doi.org/10.1016/S0378-1097(03)00921-2.
11. Thedieck K, Hain T, Mohamed W, Tindall BJ, Nimtz M, Chakraborty T, Wehland J, Jänsch L. 2006. The MprF protein is required for lysinylation of phospholipids in listerial membranes and confers resistance to cationic antimicrobial peptides (CAMPs) on Listeria monocytogenes. Mol Microbiol 62:1325-1339. http://dx.doi.org/10.1111/j.1365-2958.2006.05452.x.
12. Weidenmaier C, Peschel A, Kempf VA, Lucindo N, Yeaman MR, Bayer AS. 2005. DltABCD- and MprF-mediated cell envelope modifications of Staphylococcus aureus confer resistance to platelet microbicidal proteins and contribute to virulence in a rabbit endocarditis model. Infect Immun 73:8033-8038. http://dx.doi.org/10.1128/IAI.73.12.8033-8038.2005.
13. Baltz RH. 2009. Daptomycin: mechanisms of action and resistance, and biosynthetic engineering. Curr Opin Chem Biol 13:144-151. http://dx.doi.org/10.1016/j.cbpa.2009.02.031.
14. Cox E, Michalak A, Pagentine S, Seaton P, Pokorny A. 2014. Lysylated phospholipids stabilize models of bacterial lipid bilayers and protect against antimicrobial peptides. Biochim Biophys Acta 1838:2198-2204. http://dx.doi.org/10.1016/j.bbamem.2014.04.018.
15. Kilelee E, Pokorny A, Yeaman MR, Bayer AS. 2010. Lysyl-phosphatidylglycerol attenuates membrane perturbation rather than surface association of the cationic antimicrobial peptide 6W-RP-1 in a model membrane system: implications for daptomycin resistance. Antimicrob Agents Chemother 54:4476-4479. http://dx.doi.org/10.1128/AAC.00191-10.
16. Baltz RH, Miao V, Wrigley SK. 2005. Natural products to drugs: daptomycin and related lipopeptide antibiotics. Nat Prod Rep 22:717-741. http://dx.doi.org/10.1039/b416648p.
17. Jung D, Rozek A, Okon M, Hancock RE. 2004. Structural transitions as determinants of the action of the calcium-dependent antibiotic daptomycin. Chem Biol 11:949-957. http://dx.doi.org/10.1016/j.chembiol.2004.04.020.
18. Bertsche U, Weidenmaier C, Kuehner D, Yang SJ, Baur S, Wanner S, Francois P, Schrenzel J, Yeaman MR, Bayer AS. 2011. Correlation of daptomycin resistance in a clinical Staphylococcus aureus strain with increased cell wall teichoic acid production and D-alanylation. Antimicrob Agents Chemother 55:3922-3928. http://dx.doi.org/10.1128/AAC.01226-10.
19. Bertsche U, Yang SJ, Kuehner D, Wanner S, Mishra NN, Roth T, Nega M, Schneider A, Mayer C, Grau T, Bayer AS, Weidenmaier C. 2013. Increased cell wall teichoic acid production and D-alanylation are common phenotypes among daptomycin-resistant methicillin-resistant Staphylococcus aureus (MRSA) clinical isolates. PLoS One 8:e67398. http://dx.doi.org/10.1371/journal.pone.0067398.
20. Almeida PF, Pokorny A. 2010. Binding and permeabilization of model membranes by amphipathic peptides. Methods Mol Biol 618:155-169. http://dx.doi.org/10.1007/978-1-60761-594-1-11.
21. Kreutzberger AJ, Pokorny A. 2012. On the origin of multiphasic kinetics in peptide binding to phospholipid vesicles. J Phys Chem B 116:951-957. http://dx.doi.org/10.1021/jp209080m.